An alphabetical index of peptide and related research profiles. This is not a ranking of efficacy or scientific importance.
Tymlos
A medicine for selected osteoporosis populations at high risk of fracture.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
CT-868
Also called CT-868, an investigational treatment studied in diabetes.
The named source supports the status update below. This is not a complete clinical or safety review.
APJ agonist programs
A group of early research programs studying apelin-related signaling.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Cibinetide
Also called cibinetide, an investigational peptide studied in small-fiber nerve damage.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
BYM338
An investigational antibody studied for muscle and body-composition conditions.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Body protection compound 157
A research peptide often marketed for gut, tendon and injury recovery.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
NN9833
An investigational amylin analogue studied for weight management, alone and in combinations.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Cagrilintide + semaglutide
A studied combination of cagrilintide and semaglutide for weight and metabolic outcomes.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
CJC-1295 with DAC
An investigational growth-hormone-releasing hormone analogue.
CJC-1295 with DAC and products sold as no-DAC / modified GRF(1-29) are distinct formulations. Confirm identity from the exact product label; this inherited profile still needs a complete source review.
Trulicity
A medicine used to manage type 2 diabetes, with additional product-specific cardiovascular indications.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
SS-31
SS-31 is the research name commonly associated with elamipretide, the ingredient in Forzinity.
United States: Forzinity to improve muscle strength in adults and children with Barth syndrome weighing at least 30 kg, under accelerated approval. Other mitochondrial research and RUO SS-31 vials do not inherit this approval.
LY3841136
An investigational amylin-receptor treatment studied for obesity.
The named source supports the status update below. This is not a complete clinical or safety review.
CT-388
Also called CT-388, an investigational treatment for obesity and type 2 diabetes.
The named source supports the status update below. This is not a complete clinical or safety review.
Lipfendra
An oral peptide medicine for lowering LDL cholesterol in its labeled population.
United States: Lipfendra as an adjunct to diet and exercise to reduce LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.
Epithalon
A synthetic peptide discussed in aging and telomere research.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Copper peptide
A copper-binding peptide used in cosmetic products and discussed in skin-repair research.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
GHSR agonist programs
A research category for treatments targeting appetite and related hormone signals.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Pralmorelin
Also called pralmorelin, a peptide studied for its ability to stimulate growth-hormone release.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Growth hormone-releasing peptide 6
A growth-hormone-releasing peptide also associated with appetite effects.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
GHS pathway class
A group of research treatments that affect the release of growth hormone.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Examorelin
Also called examorelin, a growth-hormone secretagogue studied for endocrine effects.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
HN peptide
A mitochondria-associated peptide studied for cellular stress and age-related disease mechanisms.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Icotyde
An oral peptide treatment for the labeled plaque-psoriasis population.
United States: Icotyde for moderate-to-severe plaque psoriasis in adults and patients aged 12 or older weighing at least 40 kg who are candidates for systemic therapy or phototherapy.
GLP-1 multi-agonist class
A category of treatments combining gut-hormone pathways for metabolic research.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Ipamorelin acetate
A research peptide that stimulates growth-hormone release.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Lys-Pro-Val
A three-amino-acid fragment studied for inflammation-related effects.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Somatuline Depot
A medicine used for acromegaly and selected neuroendocrine tumors.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Leuprorelin
A hormone-directed medicine used in products for selected reproductive and cancer-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Linzess
An oral medicine for specific constipation-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Victoza
A GLP-1 medicine used in different products for diabetes or weight management.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Lutathera
A targeted radiation treatment for selected receptor-positive neuroendocrine tumors.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
MariTide
Also called MariTide, an investigational antibody-peptide treatment for metabolic disease.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
IBI362
A GLP-1/glucagon medicine with product-specific approvals in China and research in other populations.
China: adult chronic weight management and type 2 diabetes, according to the sponsor. This does not represent US FDA approval.
Increlex
A replacement form of IGF-1 used for a narrowly defined growth disorder.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
MT-II
An unapproved tanning peptide with effects beyond skin pigmentation.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Mitochondrial open reading frame of 12S rRNA-c
A mitochondria-derived peptide studied in metabolism and exercise-related research.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
ActRII pathway class
A research category covering several different muscle-regulatory treatments, not one medicine.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Sandostatin
A medicine used for selected conditions involving excessive hormone release.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
ALT-801
An investigational treatment studied for obesity and metabolic liver disease.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
ZP8396
An investigational long-acting amylin analogue studied for obesity.
The named source supports the status update below. This is not a complete clinical or safety review.
MET-097i
An investigational long-acting GLP-1 treatment also known as MET-097i.
The named source supports the status update below. This is not a complete clinical or safety review.
Trulance
An oral medicine for certain chronic constipation conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
LY3437943
An investigational medicine being studied for obesity, type 2 diabetes and related conditions.
The named source supports the status update below. This is not a complete clinical or safety review.
Mimrylo
A hepcidin-mimicking treatment for the labeled polycythemia vera population.
United States: Mimrylo for erythrocytosis in adults with polycythemia vera.
TP-7
A synthetic peptide studied for anxiety-related and immune effects.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Ozempic
A medicine used in specific products for type 2 diabetes and weight management.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
ACTH(4-7)-PGP
A synthetic peptide discussed in neurological and cognitive research.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
GHRH(1-29)
A growth-hormone-releasing hormone analogue with a history of medical use and current product-specific questions.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Recombinant human growth hormone
A manufactured version of human growth hormone used for specific diagnosed conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
BI 456906
An investigational medicine studied for obesity and metabolic liver disease.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Thymosin beta-4 fragment
A commercial research label associated with thymosin beta-4-related products.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Gattex
A medicine for selected people with short bowel syndrome.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Forteo
A bone-building medicine for certain people with osteoporosis and high fracture risk.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Egrifta
A medicine for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Thymalfasin
Also called thymalfasin, a peptide studied for immune-related conditions.
The FDA source addresses safety uncertainties; it is not evidence that the advertised benefits are proven.
Tβ4
A naturally occurring peptide studied in tissue repair, including specific experimental formulations.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Mounjaro
A medicine used in Mounjaro for type 2 diabetes and Zepbound for specific weight-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
VANQUISH asset
An investigational dual-hormone treatment studied for weight management.
This inherited overview has not completed a record-level source review. Reference directories are starting points, not citations supporting every claim.
Amycretin
Zenagamtide, previously called amycretin, is studied for weight and metabolic outcomes.
The named source supports the status update below. This is not a complete clinical or safety review.
Prialt
A specialist medicine used for severe chronic pain in selected patients.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.